MedTrace Logo

Continuous Transcutaneous Electrical Stimulation in Sleep Apnoea

NCT01661712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2018-12-06

Study results available
· View outcomes & findings →

Summary

The aim of this randomized, double-blinded, sham-controlled cross-over trial is to demonstrate the effectiveness of continuous transcutaneous electrical stimulation of the pharyngeal dilator muscles to reduce sleep-disordered breathing.

Conditions

  • Obstructive Sleep Apnoea

Interventions

DEVICE

Transcutaneous electrical stimulation

Transcutaneous electrical stimulation (one night of electrical current titrated according to skin sensation)

DEVICE

Sham stimulation

Sham stimulation for one night (no electrical stimulation)

Sponsors & Collaborators

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Joerg Steier, MD, PhD · Guy´s & St Thomas´ NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01661712 on ClinicalTrials.gov